UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1068) 1068
life sciences & biomedicine (1052) 1052
male (884) 884
fluorobenzenes - pharmacology (860) 860
rosuvastatin calcium (800) 800
animals (791) 791
humans (740) 740
pharmacology & pharmacy (583) 583
rats (437) 437
female (433) 433
sulfonamides - pharmacology (433) 433
pyrimidines - pharmacology (420) 420
rosuvastatin (369) 369
fluorobenzenes - therapeutic use (347) 347
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (344) 344
sulfonamides - therapeutic use (300) 300
pyrimidines - therapeutic use (298) 298
middle aged (274) 274
dose-response relationship, drug (254) 254
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (247) 247
piperidines - pharmacology (228) 228
statins (216) 216
mice (214) 214
rats, sprague-dawley (207) 207
adult (202) 202
serotonin antagonists - pharmacology (197) 197
fluorobenzenes - administration & dosage (195) 195
cardiovascular system & cardiology (191) 191
aged (189) 189
fluorobenzenes - pharmacokinetics (175) 175
neurosciences & neurology (174) 174
neurosciences (172) 172
cardiac & cardiovascular systems (151) 151
pyrimidines - administration & dosage (144) 144
sulfonamides - administration & dosage (144) 144
fluorobenzenes - adverse effects (123) 123
drug interactions (121) 121
sulfonamides - pharmacokinetics (120) 120
pyrimidines - pharmacokinetics (119) 119
time factors (119) 119
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (112) 112
atorvastatin calcium (111) 111
rats, wistar (111) 111
treatment outcome (111) 111
sulfonamides - adverse effects (109) 109
antilipemic agents (108) 108
pyrimidines - adverse effects (108) 108
cholesterol (102) 102
cholesterol, ldl - blood (99) 99
fluorobenzenes - chemistry (97) 97
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (96) 96
analysis (92) 92
hydroxymethylglutaryl-coa reductase inhibitors - pharmacokinetics (91) 91
disease models, animal (90) 90
hypercholesterolemia - drug therapy (90) 90
serotonin receptor agonists - pharmacology (81) 81
fluorobenzenes - metabolism (80) 80
research (80) 80
biochemistry & molecular biology (79) 79
chemistry (77) 77
lipids (77) 77
5-ht (76) 76
abridged index medicus (75) 75
cells, cultured (75) 75
indoles - pharmacology (75) 75
peripheral vascular disease (75) 75
receptor, serotonin, 5-ht2a (75) 75
double-blind method (74) 74
fluorobenzenes (74) 74
receptors, serotonin - drug effects (71) 71
serotonin (71) 71
statin (71) 71
physical sciences (70) 70
atherosclerosis (68) 68
fluorobenzenes - blood (66) 66
drug therapy, combination (65) 65
mice, inbred c57bl (65) 65
toxicology (65) 65
pyrroles - pharmacology (64) 64
behavior, animal - drug effects (63) 63
cardiovascular (63) 63
drug therapy (62) 62
heptanoic acids - pharmacology (62) 62
heptanoic acids - therapeutic use (60) 60
pyrroles - therapeutic use (60) 60
psychiatry (59) 59
general & internal medicine (57) 57
pyrimidines (56) 56
risk factors (56) 56
in vitro techniques (55) 55
pharmacology/toxicology (55) 55
receptor, serotonin, 5-ht2a - metabolism (55) 55
sulfonamides (55) 55
atorvastatin (54) 54
medicine, general & internal (54) 54
cholesterol - blood (53) 53
motor activity - drug effects (53) 53
chemistry, medicinal (52) 52
triglycerides - blood (52) 52
dosage and administration (51) 51
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1414) 1414
Japanese (14) 14
Chinese (10) 10
German (8) 8
Russian (7) 7
Italian (5) 5
French (4) 4
Spanish (4) 4
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug metabolism and disposition, ISSN 1521-009X, 09/2012, Volume 40, Issue 9, pp. 1744 - 1756
Interindividual variability in activity of uptake transporters is evident in vivo, yet limited data exist in vitro, confounding in vitro-in vivo extrapolation.... 
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antihypertensive Agents - pharmacology | Tetrazoles - pharmacology | Species Specificity | Valsartan | Hypoglycemic Agents - metabolism | Benzoates - metabolism | Humans | Antihypertensive Agents - metabolism | Hepatocytes - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 1 Receptor Blockers - metabolism | Organic Anion Transporters - metabolism | Pyrimidines - metabolism | Quinolines - pharmacology | Tetrazoles - metabolism | Carbamates - metabolism | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Drug Interactions | Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism | Biological Transport | Piperidines - pharmacology | Hepatocytes - drug effects | Carbamates - pharmacology | Pravastatin - pharmacology | Fluorobenzenes - metabolism | Piperidines - metabolism | Pravastatin - metabolism | Valine - analogs & derivatives | Rats | Rosuvastatin Calcium | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Hypoglycemic Agents - pharmacology | Quinolines - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Valine - metabolism | Models, Biological | Benzimidazoles - metabolism | Sulfonamides - metabolism | Benzoates - pharmacology | Benzimidazoles - pharmacology | Kinetics | Valine - pharmacology | Organic Anion Transporters - drug effects | Index Medicus
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2014, Volume 231, Issue 1, pp. 269 - 281
Journal Article
Journal Article
Pharmacological research, ISSN 1043-6618, 09/2011, Volume 64, Issue 3, pp. 180 - 186
Statins, long known to be beneficial in conditions where dyslipidemia occurs by lowering serum cholesterol levels, also have been proposed for use in... 
Alzheimer disease | Pleiotropic functions | Statins | Statins as Janus molecules | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Fatty Acids, Monounsaturated - pharmacology | Lovastatin - pharmacology | Heptanoic Acids - therapeutic use | Humans | Heptanoic Acids - adverse effects | Neurodegenerative Diseases - drug therapy | Quinolines - pharmacology | Fluorobenzenes - pharmacology | Fatty Acids, Monounsaturated - therapeutic use | Fatty Acids, Monounsaturated - adverse effects | Pyrroles - adverse effects | Indoles - pharmacology | Pyrroles - therapeutic use | Heptanoic Acids - pharmacology | Lovastatin - therapeutic use | Lovastatin - adverse effects | Alzheimer Disease - drug therapy | Rosuvastatin Calcium | Pyrimidines - pharmacology | Cholesterol - metabolism | Sulfonamides - pharmacology | Atorvastatin Calcium | Pyrroles - pharmacology | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Indoles - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Indoles - therapeutic use | Fluorobenzenes - adverse effects | Quinolines - therapeutic use | Fluorobenzenes - therapeutic use | Quinolines - adverse effects | Alzheimer's disease | Neuroprotection | Neurotoxicity | Neurodegenerative diseases | statins | Dyslipidemia | Clinical trials | Age | Cholesterol | Index Medicus
Journal Article
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 05/2008, Volume 325, Issue 2, pp. 577 - 587
Journal Article
European heart journal, ISSN 0195-668X, 09/2012, Volume 33, Issue 17, pp. 2151 - 2162
Aims CYP3A4-metabolized statins can influence the pharmacodynamic effect of clopidogrel. We sought to assess the impact of switching to a... 
Atorvastatin | Clopidogrel | Platelet | Non-CYP3A4-metabolized statin | High platelet reactivity | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Prospective Studies | Ticlopidine - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Cytochrome P-450 CYP3A - physiology | Male | Pyrimidines - metabolism | Fluorobenzenes - pharmacology | Cytochrome P-450 CYP3A - genetics | Platelet Aggregation Inhibitors - pharmacology | Female | Aspirin - therapeutic use | Platelet Aggregation - drug effects | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Pyrroles - therapeutic use | Pravastatin - therapeutic use | Heptanoic Acids - pharmacology | Pravastatin - pharmacology | Fluorobenzenes - metabolism | Pravastatin - metabolism | Rosuvastatin Calcium | Genotype | Coronary Artery Disease - drug therapy | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Ticlopidine - analogs & derivatives | Adenosine Diphosphate - pharmacology | Pyrroles - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Sulfonamides - metabolism | Drug Substitution | Fluorobenzenes - therapeutic use | Percutaneous Coronary Intervention | Index Medicus
Journal Article
The Journal of Physiology, ISSN 0022-3751, 05/2004, Volume 556, Issue 3, pp. 739 - 754
Previous studies have outlined an important role for serotonin (5-HT) in the development of synaptic connectivity and function in the cerebral cortex. In this... 
Neurosciences | Physiology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Receptors, Serotonin - physiology | Lidocaine - pharmacology | Serotonin - physiology | Amphetamines - pharmacology | Male | Serotonin - pharmacology | Serotonin 5-HT4 Receptor Antagonists | Fluorobenzenes - pharmacology | Serotonin 5-HT2 Receptor Antagonists | Pindolol - pharmacology | Prefrontal Cortex - drug effects | Piperidines - pharmacology | Time Factors | Pyramidal Cells - physiology | 6-Cyano-7-nitroquinoxaline-2,3-dione - pharmacology | Indoles - pharmacology | Pyramidal Cells - drug effects | Tetrodotoxin - pharmacology | Phenols - pharmacology | Synapses - drug effects | GABA-A Receptor Antagonists | Glutamic Acid - pharmacology | Receptors, AMPA - physiology | Synapses - physiology | Rats | Sodium Channel Blockers - pharmacology | Bicuculline - pharmacology | Pindolol - analogs & derivatives | Prefrontal Cortex - cytology | Serotonin Antagonists - pharmacology | Sulfonamides - pharmacology | Rats, Sprague-Dawley | Lidocaine - analogs & derivatives | Patch-Clamp Techniques | Receptor, Serotonin, 5-HT2A - physiology | Animals | Receptors, Serotonin, 5-HT4 - physiology | Prefrontal Cortex - physiology | Receptors, Metabotropic Glutamate - antagonists & inhibitors | Serotonin 5-HT1 Receptor Antagonists | Receptors, AMPA - antagonists & inhibitors | Index Medicus | Research Papers
Journal Article